Pfizer: Messy Q4 Earnings Mask An Improving Business (NYSE:PFE)

Core Insights - Pfizer Inc. reported Q4 and full-year 2025 earnings, which were solid overall but missed estimates in certain areas, leading to a ~5% decline in shares during pre-market trading [1] Financial Performance - The earnings report indicated that while the overall performance was solid, specific metrics did not meet market expectations, prompting a negative reaction from investors [1] Market Reaction - The immediate selling pressure on Pfizer's shares was attributed to the earnings miss, reflecting investor sentiment and market dynamics following the announcement [1]